Please assess the completion status of the following clinical trial:

Trial Title: A Study of the Effects of Topical Capsaicin in the Treatment of Provoked Vestibulodynia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Provoked vulvodynia, rated B2a according to 2003 International Society for the Study of Vulvovaginal Disease (ISSVD) classification~* Pain ≥ 4 on Visual Analogic Scale (VAS)~* Subject refractory to at least 2 conventional treatments (tricyclic antidepressants, anticonvulsants at analgesic doses , biofeedback physical therapy, psychological assessment in a context of chronic pain) or to botulinum toxin A~* If a former treatment with botulinum toxin A was performed: patient must be in treatment failure (= no decrease over 50% of the pain 3 months after initiation of the treatment)~* Negative screening test results~* Menopause, surgically sterilized women or women using effective contraceptive method~* Good understanding and predictable adherence to the protocol~* Beneficiary/affiliated to French social security/social healthcare~* Signed Informed Consent Form~Exclusion Criteria:~* Predictable poor adherence~* Pregnant or breastfeeding women~* Diabetes mellitus type 1 or type 2~* Major mental disorders~* Underlying etiology such as chronic vulvar disease~* Initial vulvar erythema~* Vulnerable subjects (particularly adults under guardianship)~* Ongoing medical treatment with tricyclic antidepressants or anticonvulsants at analgesic doses~Subject refractory to conventional treatments (tricyclic antidepressants and benzodiazepines doses analgesics, physiotherapy type of biofeedback)~Good understanding and predictable adherence to the protocol beneficiary/affiliated to French social security/social healthcare signed Informed Consent Form

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Capsaicin patch (Type: EXPERIMENTAL): Cuttable capsaicin patch. 2 patches of 4 cm² (2 x 2cm), for a total of 2.5 mg of capsaicin.

Based on this trial design, predict the completion outcome and termination type (if applicable).